150 related articles for article (PubMed ID: 31104103)
1. The co-segregation of the MYL2 R58Q mutation in Chinese hypertrophic cardiomyopathy family and its pathological effect on cardiomyopathy disarray.
Yin K; Ma Y; Cui H; Sun Y; Han B; Liu X; Zhao K; Li W; Wang J; Wang H; Wang S; Zhou Z
Mol Genet Genomics; 2019 Oct; 294(5):1241-1249. PubMed ID: 31104103
[TBL] [Abstract][Full Text] [Related]
2. Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with MYL2-R58Q-Mediated Apical Hypertrophic Cardiomyopathy Show Hypertrophy, Myofibrillar Disarray, and Calcium Perturbations.
Zhou W; Bos JM; Ye D; Tester DJ; Hrstka S; Maleszewski JJ; Ommen SR; Nishimura RA; Schaff HV; Kim CS; Ackerman MJ
J Cardiovasc Transl Res; 2019 Oct; 12(5):394-403. PubMed ID: 30796699
[TBL] [Abstract][Full Text] [Related]
3. Phosphomimetic-mediated in vitro rescue of hypertrophic cardiomyopathy linked to R58Q mutation in myosin regulatory light chain.
Yadav S; Kazmierczak K; Liang J; Sitbon YH; Szczesna-Cordary D
FEBS J; 2019 Jan; 286(1):151-168. PubMed ID: 30430732
[TBL] [Abstract][Full Text] [Related]
4. Hypertrophic cardiomyopathy mutation R58Q in the myosin regulatory light chain perturbs thick filament-based regulation in cardiac muscle.
Kampourakis T; Ponnam S; Irving M
J Mol Cell Cardiol; 2018 Apr; 117():72-81. PubMed ID: 29452157
[TBL] [Abstract][Full Text] [Related]
5. Systematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathy.
Kabaeva ZT; Perrot A; Wolter B; Dietz R; Cardim N; Correia JM; Schulte HD; Aldashev AA; Mirrakhimov MM; Osterziel KJ
Eur J Hum Genet; 2002 Nov; 10(11):741-8. PubMed ID: 12404107
[TBL] [Abstract][Full Text] [Related]
6. A Novel Missense Mutation p.Gly162Glu of the Gene MYL2 Involved in Hypertrophic Cardiomyopathy: A Pedigree Analysis of a Proband.
Renaudin P; Janin A; Millat G; Chevalier P
Mol Diagn Ther; 2018 Apr; 22(2):219-223. PubMed ID: 29549657
[TBL] [Abstract][Full Text] [Related]
7. Slow-twitch skeletal muscle defects accompany cardiac dysfunction in transgenic mice with a mutation in the myosin regulatory light chain.
Kazmierczak K; Liang J; Yuan CC; Yadav S; Sitbon YH; Walz K; Ma W; Irving TC; Cheah JX; Gomes AV; Szczesna-Cordary D
FASEB J; 2019 Mar; 33(3):3152-3166. PubMed ID: 30365366
[TBL] [Abstract][Full Text] [Related]
8. Novel frameshift variant in MYL2 reveals molecular differences between dominant and recessive forms of hypertrophic cardiomyopathy.
Manivannan SN; Darouich S; Masmoudi A; Gordon D; Zender G; Han Z; Fitzgerald-Butt S; White P; McBride KL; Kharrat M; Garg V
PLoS Genet; 2020 May; 16(5):e1008639. PubMed ID: 32453731
[TBL] [Abstract][Full Text] [Related]
9. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR
Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739
[TBL] [Abstract][Full Text] [Related]
10. Gene expression patterns in transgenic mouse models of hypertrophic cardiomyopathy caused by mutations in myosin regulatory light chain.
Huang W; Kazmierczak K; Zhou Z; Aguiar-Pulido V; Narasimhan G; Szczesna-Cordary D
Arch Biochem Biophys; 2016 Jul; 601():121-32. PubMed ID: 26906074
[TBL] [Abstract][Full Text] [Related]
11. A Potential Oligogenic Etiology of Hypertrophic Cardiomyopathy: A Classic Single-Gene Disorder.
Li L; Bainbridge MN; Tan Y; Willerson JT; Marian AJ
Circ Res; 2017 Mar; 120(7):1084-1090. PubMed ID: 28223422
[TBL] [Abstract][Full Text] [Related]
12. Novel phenotype-genotype correlations of hypertrophic cardiomyopathy caused by mutation in α-actin and myosin-binding protein genes in three unrelated Chinese families.
Yang QL; Bian YY; Wang B; Zuo L; Zhou MY; Shao H; Zhang YM; Liu LW
J Cardiol; 2019 May; 73(5):438-444. PubMed ID: 30600190
[TBL] [Abstract][Full Text] [Related]
13. [P1208fs mutation in the cardiac myosin binding protein C is associated with hypertrophic cardiomyopathy in a Chinese pedigree].
Li J; Liu LW; Na LS; Zuo L; Qi W; Liu Y; Shao H; Ma ZL; Wang LF
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Apr; 44(4):321-6. PubMed ID: 27112610
[TBL] [Abstract][Full Text] [Related]
14. Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy.
Flavigny J; Richard P; Isnard R; Carrier L; Charron P; Bonne G; Forissier JF; Desnos M; Dubourg O; Komajda M; Schwartz K; Hainque B
J Mol Med (Berl); 1998 Mar; 76(3-4):208-14. PubMed ID: 9535554
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of 4 Korean families with hypertrophic cardiomyopathy caused by 4 different mutations.
Choi JO; Yu CW; Chun Nah J; Rang Park J; Lee BS; Jeong Choi Y; Cho BR; Lee SC; Woo Park S; Kimura A; Euy Park J
Clin Cardiol; 2010 Jul; 33(7):430-8. PubMed ID: 20641121
[TBL] [Abstract][Full Text] [Related]
16. Hypertrophic remodelling in cardiac regulatory myosin light chain (MYL2) founder mutation carriers.
Claes GR; van Tienen FH; Lindsey P; Krapels IP; Helderman-van den Enden AT; Hoos MB; Barrois YE; Janssen JW; Paulussen AD; Sels JW; Kuijpers SH; van Tintelen JP; van den Berg MP; Heesen WF; Garcia-Pavia P; Perrot A; Christiaans I; Salemink S; Marcelis CL; Smeets HJ; Brunner HG; Volders PG; van den Wijngaard A
Eur Heart J; 2016 Jun; 37(23):1815-22. PubMed ID: 26497160
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of genotype and phenotype correlation of MYH7-V878A mutation among ethnic Han Chinese pedigrees affected with hypertrophic cardiomyopathy].
Wang B; Guo R; Zuo L; Shao H; Liu Y; Wang Y; Ju Y; Sun C; Wang L; Zhang Y; Liu L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Aug; 34(4):514-518. PubMed ID: 28777849
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the cardiac troponin T gene show various prognoses in Japanese patients with hypertrophic cardiomyopathy.
Fujita E; Nakanishi T; Nishizawa T; Hagiwara N; Matsuoka R
Heart Vessels; 2013 Nov; 28(6):785-94. PubMed ID: 23494605
[TBL] [Abstract][Full Text] [Related]
19. Sudden cardiac death in hypertrophic cardiomyopathy. Variability in phenotypic expression of beta-myosin heavy chain mutations.
Marian AJ; Mares A; Kelly DP; Yu QT; Abchee AB; Hill R; Roberts R
Eur Heart J; 1995 Mar; 16(3):368-76. PubMed ID: 7789380
[TBL] [Abstract][Full Text] [Related]
20. A novel nonsense mutation in TNNT2 in a Chinese pedigree with hypertrophic cardiomyopathy: A case report.
Gao G; Liu G; Chen W; Tong Y; Mao C; Liu J; Zhang X; He MM; Yang P
Medicine (Baltimore); 2020 Aug; 99(34):e21843. PubMed ID: 32846832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
